IDEXX Laboratories to Release 2024 Second Quarter Financial Results

IDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 second quarter results for Tuesday, August 6, 2024, before the market opens. The Company will

BusinesswireJun 24 23:00

IDEXX Labs Is Maintained at Hold by Stifel

IDEXX Labs Is Maintained at Hold by Stifel

Dow JonesJun 24 21:05

IDEXX Laboratories Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/24/2024 2.88% Stifel $520 → $510 Maintains Hold 05/14/2024 20.23% Morgan Stanley $620 → $596 Maintains

BenzingaJun 24 20:54

Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage

Simply Wall StJun 24 20:11

Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $510

Stifel analyst Jonathan Block maintains $IDEXX Laboratories Inc(IDXX.US)$ with a hold rating, and adjusts the target price from $520 to $510.According to TipRanks data, the analyst has a success rate

Futu NewsJun 24 19:33 · Ratings

Express News | IDEXX Laboratories Inc : Stifel Cuts Target Price to $510 From $520

BreakingsJun 24 19:16